This site uses cookies to bring you the best experience. Find out more
Skip to main content

News

Find Out The Latest

Keep in touch with exciting developments from The Oxford Science Park and its occupiers here.

Contact us on comms@oxfordsp.com if you would like to know more about any of these stories.

You can also follow us on X or LinkedIn  


Theolytics awarded significant £2M Transforming Cancer Therapeutics grant from Innovate UK

Theolytics, a clinical-stage biotechnology company developing next-generation oncolytic viral therapies, has been awarded £2M from Innovate UK’s prestigious Transforming Cancer Therapeutics grant funding competition to support the clinical development of its lead candidate THEO-260. This non-dilutive funding adds to the £19M raised earlier this year from a strong investor syndicate comprising M Ventures, Taiho Ventures, Epidarex Capital,... Read more

Exscientia and Recursion Enter Definitive Agreement

Recursion and Exscientia plc have announced the companies have entered into a definitive agreement, combining Recursion, a leading clinical stage technology-enabled biotech company decoding biology to industrialize drug discovery, with Exscientia, a technology-driven clinical stage drug design and development company, committed to creating more effective medicines for patients, faster. Chris Gibson, Co-Founder and CEO of Recursion as well as... Read more

Ellison Institute expands to new building on The Oxford Science Park to accommodate growth

The Ellison Institute of Technology Oxford (EIT) is expanding into Winchester House on The Oxford Science Park to accommodate for significant growth and an anticipated tripling in headcount over the coming years. The phased move, starting this month, will see the interdisciplinary research and development facility EIT taking full occupancy of Winchester House throughout the remainder of the year. Winchester House was built in 2008... Read more

Mace awarded contract to deliver The Daubeny Project at The Oxford Science Park

Mace has been awarded a £184 million contract to deliver the next expansion phase at The Oxford Science Park, The Daubeny Project. This landmark project will see the construction of three new state-of-the-art laboratory and office buildings, further cementing Oxford's position as a world-leading centre for scientific innovation. The expansion will add 400,500 sq ft of premium laboratory and office space to the park, addressing the critical... Read more

Moa harvests global deal for new herbicide

Oxford, UK  8 July2024 – Agricultural biotech firm Moa Technology has signed a research and commercial partnership with Nufarm,a global agricultural innovator based in Melbourne, Australia. Moa has discovered several promising new classes of herbicide with its breakthrough innovation platform, which are currently in field trials in the US, UK, France and Spain. The deal provides Nufarm exclusive access to a new mode of action product in one... Read more

The Daubeny Project

Imaginative design, inspiring spaces.